Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 462

1.

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.

Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S.

Arch Gen Psychiatry. 1999 Apr;56(4):330-6.

PMID:
10197827
3.

Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder.

Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN.

Arch Gen Psychiatry. 1995 Jun;52(6):444-55. Erratum in: Arch Gen Psychiatry 1995 Oct;52(10):836.

PMID:
7771914
4.

Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder.

Gadow KD, Sverd J, Nolan EE, Sprafkin J, Schneider J.

J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):840-8.

PMID:
17581448
5.

Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder.

Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J.

J Clin Psychopharmacol. 2002 Jun;22(3):267-74.

PMID:
12006897
6.
7.

Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.

Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schneider J.

J Child Neurol. 2008 Sep;23(9):981-90. doi: 10.1177/0883073808315412. Epub 2008 May 12.

PMID:
18474932
8.

Treatment of ADHD in children with tics: a randomized controlled trial.

Tourette's Syndrome Study Group..

Neurology. 2002 Feb 26;58(4):527-36.

PMID:
11865128
9.

Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate.

Nolan EE, Gadow KD.

J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):597-604.

PMID:
9136493
10.

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.

Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, Tarazi R, Faraone SV.

Arch Gen Psychiatry. 2002 Jul;59(7):649-56.

PMID:
12090818
11.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
12.

A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.

Findling RL, Bukstein OG, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD.

J Clin Psychiatry. 2008 Jan;69(1):149-59. Erratum in: J Clin Psychiatry. 2008 Feb;69(2):329.

PMID:
18312050
13.

Methylphenidate and comorbid anxiety disorder in children with both chronic multiple tic disorder and ADHD.

Gadow KD, Nolan EE.

J Atten Disord. 2011 Apr;15(3):246-56. doi: 10.1177/1087054709356405. Epub 2010 Apr 8.

PMID:
20378921
14.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
15.

Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.

Gadow KD, Sverd J.

Adv Neurol. 2006;99:197-207. Review. No abstract available.

PMID:
16536367
16.

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings.

Gadow KD, Nolan EE, Sverd J.

J Am Acad Child Adolesc Psychiatry. 1992 May;31(3):462-71.

PMID:
1592778
17.

Drug and non-drug treatments of children with ADHD and tic disorders.

Poncin Y, Sukhodolsky DG, McGuire J, Scahill L.

Eur Child Adolesc Psychiatry. 2007 Jun;16 Suppl 1:78-88. doi: 10.1007/s00787-007-1010-8. Review. Erratum in: Eur Child Adolesc Psychiatry. 2007 Dec;16(8):537.

PMID:
17665286
19.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network..

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
20.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303

Supplemental Content

Support Center